6866. Various prescription drugs.    (F.D.C. No. 46583.   S. Nos. 75/85 T.)
QUANTITY : 8,355 tablets and capsules and 204 containers of salves and liquids, 
and 1 227-tablet btl. labeled Miluretic, at Macclenny, Fla., in possession of 
Paul's Drug Store.
SHIPPED :    On unknown dates, by various drug handlers.
LABEL IN PART: (Some labels) "Professional Sample," "Physician's Sample," 
"Sample: Not To Be Sold," "Clinical Trial Supply," or similar wording.
RESULTS OP INVESTIGATION : Some of the articles which had not been repacked 
by the dealer consisted of quantities of prescription drugs originally intended 
for use as samples for physicians and others lawfully engaged in dispensing 
prescription drugs, and bearing labels containing the words "Clinical Trial 
Supply," or similar wording, and the names of the manufacturers, packers, or 
distributors located outside the State of Florida. Some of the articles con- 
sisted of quantities of prescription drugs which had been repacked from phy- 
sicians' samples into containers which had labels bearing the brand names of 
the drugs, a "complimentary-not for sale" professional sample legend, and 
the names of manufacturers, packers, or distributors located outside the State 
of Florida.
LIBELED :    10-23-61, S. Dist. Fla.
CHARGE: 502(a)-while held for sale, the words "Professional Sample," 
"Physician's Sample," "Sample: Not To Be Sold," "Clinical Trial Supply," 
and similar wording on the labels of some of the articles, were false and 
misleading as applied to the articles in the possession of a repacker and 
intended for sale and not intended for use as "complimentary-not for sale" 
samples for physicians and others lawfully engaged in dispensing prescrip- 
tion drugs; 502(f) (1)-the labeling of some of the articles failed to bear 
adequate directions for use and they were not exempt from that requirement 
since they were drugs subject to the provisions of 503(b) (1) and their labels 
failed to bear an identifying lot or control number from which it was possible 
to determine the complete manufacturing history of the package of the 
drugs, as required by regulations; 501(d)(2)-tablets which were not 
Miluretic tablets had been substituted in part for Miluretic tablets in the 
227-tablet btl. labeled "Miluretic"; and 502(a)-the name "Miluretic" on 
the label of one 227-tablet btl. was false and misleading in that such name 
represented that the article consisted entirely of Miluretic tablets, whereas 
the article did not consist entirely of such tablets but did consist in part of 
other tablets.
DISPOSITION :   11-27-61.   Default-destruction.